Literature DB >> 24892021

Variable change in renal function by hypertonic saline.

Jesse J Corry1, Panayiotis Varelas1, Tamer Abdelhak1, Stacey Morris1, Marlisa Hawley1, Allison Hawkins1, Michelle Jankowski1.   

Abstract

AIM: To investigate the effects of hypertonic saline in the neurocritical care population.
METHODS: We retrospectively reviewed our hospital's use of hypertonic saline (HS) since March of 2005, and prospectively since October 2010. Comparisons were made between admission diagnoses, creatinine change (Cr), and HS formulation (3% NaCl, 3% NaCl/sodium acetate mix, and 23.4% NaCl) to patients receiving normal saline or lactated ringers. The patients (n = 1329) of the retrospective portion were identified. The data presented represents the first 230 patients with data.
RESULTS: Significant differences in Acute Physiology and Chronic Health Evaluation II scores and Glasgow Coma Scale scores occurred between different saline formulations. No significant correlation of Cl(-) or Na(+) with Cr, nor with saline types, occurred. When dichotomized by diagnosis, significant correlations appear. Traumatic brain injury (TBI) patients demonstrated moderate correlation between Na(+) and Cr of 0.45. Stroke patients demonstrated weak correlations between Na(+) and Cr, and Cl(-) and Cr (0.19 for both). Patients receiving HS and not diagnosed with intracerebral hemorrhage, stroke, subarachnoid hemorrhage, or TBI demonstrated a weak but significant correlation between Cl(-) and Cr at 0.29.
CONCLUSION: Cr directly correlates with Na(+) or Cl(-) in stroke, Na(+) in TBI, and Cl(-) in other populations. Prospective comparison of HS and renal function is needed.

Entities:  

Keywords:  Acute kidney injury; Cerebral edema; Critical care; Hypertonic saline solution; Sodium chloride

Year:  2014        PMID: 24892021      PMCID: PMC4038814          DOI: 10.5492/wjccm.v3.i2.61

Source DB:  PubMed          Journal:  World J Crit Care Med        ISSN: 2220-3141


  53 in total

1.  Augmented creatinine clearance in traumatic brain injury.

Authors:  Andrew Udy; Robert Boots; Siva Senthuran; Janine Stuart; Renae Deans; Melissa Lassig-Smith; Jeffrey Lipman
Journal:  Anesth Analg       Date:  2010-11-03       Impact factor: 5.108

2.  Transient renal impairment in acute intracerebral haemorrhage.

Authors:  U K Misra; J Kalita; M Srivastava; S K Mandal
Journal:  J Neurol       Date:  1996-05       Impact factor: 4.849

3.  Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome.

Authors:  Noa Molshatzki; David Orion; Rakefet Tsabari; Yvonne Schwammenthal; Oleg Merzeliak; Maya Toashi; David Tanne
Journal:  Cerebrovasc Dis       Date:  2010-12-21       Impact factor: 2.762

4.  Hypertonic saline ameliorates cerebral edema through downregulation of aquaporin-4 expression in the astrocytes.

Authors:  H K Zeng; Q S Wang; Y Y Deng; M Fang; C B Chen; Y H Fu; W Q Jiang; X Jiang
Journal:  Neuroscience       Date:  2010-01-18       Impact factor: 3.590

5.  Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.

Authors:  Nor'azim Mohd Yunos; Rinaldo Bellomo; Colin Hegarty; David Story; Lisa Ho; Michael Bailey
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

6.  Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen.

Authors:  Gaylan L Rockswold; Craig A Solid; Eduardo Paredes-Andrade; Sarah B Rockswold; Jon T Jancik; Robert R Quickel
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

7.  Regulation of renal blood flow by plasma chloride.

Authors:  C S Wilcox
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery.

Authors:  S Scheingraber; M Rehm; C Sehmisch; U Finsterer
Journal:  Anesthesiology       Date:  1999-05       Impact factor: 7.892

9.  Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients.

Authors:  Yasser Sakr; Steffen Rother; Alberto Mendonca Pires Ferreira; Christian Ewald; Pedro Dünisch; Niels Riedemmann; Konrad Reinhart
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

Review 10.  Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure.

Authors:  G F Strandvik
Journal:  Anaesthesia       Date:  2009-09       Impact factor: 6.955

View more
  4 in total

Review 1.  Intracerebral Hemorrhage: Perihemorrhagic Edema and Secondary Hematoma Expansion: From Bench Work to Ongoing Controversies.

Authors:  Manoj K Mittal; Aaron LacKamp
Journal:  Front Neurol       Date:  2016-11-21       Impact factor: 4.003

2.  Cotreatment with Furosemide and Hypertonic Saline Decreases Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) and Serum Creatinine Concentrations in Traumatic Brain Injury: A Randomized, Single-Blind Clinical Trial.

Authors:  Marziye Jafari; Shahram Ala; Kaveh Haddadi; Abbas Alipour; Mojtaba Mojtahedzadeh; Saeid Ehteshami; Saeid Abediankenari; Misagh Shafizad; Ebrahim Salehifar; Foroogh Khalili
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

3.  Low-chloride versus high-chloride hypertonic solution for the treatment of subarachnoid hemorrhage-related complications (The ACETatE trial): study protocol for a pilot randomized controlled trial.

Authors:  Ofer Sadan; Owen Samuels; William H Asbury; John J Hanfelt; Kai Singbartl
Journal:  Trials       Date:  2018-11-14       Impact factor: 2.279

4.  Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.

Authors:  Aaron M Cook; G Morgan Jones; Gregory W J Hawryluk; Patrick Mailloux; Diane McLaughlin; Alexander Papangelou; Sophie Samuel; Sheri Tokumaru; Chitra Venkatasubramanian; Christopher Zacko; Lara L Zimmermann; Karen Hirsch; Lori Shutter
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.